Federal Register
Notices
> Manufacturers 2008 >
Research Triangle Institute
FR Doc E8-18067[Federal Register: August 6, 2008 (Volume 73, Number 152)]
[Notices] [Page 45789] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-106]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 9, 2008, and published in the Federal Register on April
16, 2008, (73 FR 20718), Research Triangle Institute, Kenneth H. Davis Jr.,
Hermann Building, East Institute Drive, P.O. Box 12194, Research Triangle, North
Carolina 27709, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
Drug
|
Schedule
|
Marihuana (7360)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Cocaine (9041)
|
II
|
The Institute will manufacture small quantities of cocaine and marihuana
derivatives for use by their customers in analytical kits, reagents, and
reference standards as directed by the National Institute on Drug Abuse.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Research Triangle
Institute to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated Research
Triangle Institute to ensure that the company's registration is consistent with
the public interest. The investigation has included inspection and testing of
the company's physical security systems, verification of the company's
compliance with State and local laws, and a review of the company's background
and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-18067 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|